Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Safety, Tolerability and Pharmacokinetics of Single Oral Dose of JX11502MA Capsule on Healthy Human: A Phase Ia, Single Center, Randomized Clinical Trial

NCT05233657 is registered in ClinicalTrials.gov with Zhejiang Jingxin Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05233657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Safety, Tolerability and Pharmacokinetics of Single Oral Dose of JX11502MA Capsule on Healthy Human: A Phase Ia, Single Center, Randomized Clinical Trial
Lead sponsor
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
January 4, 2020
Completion date
February 28, 2022
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia